Antiprogestins — A New Challenge for Female Contraception
| Autor: | Kristina Gemzell Danielsson, Lena Marions, M.L. Swahn, M Bygdeman |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Gynecology
medicine.medical_specialty biology medicine.drug_class business.industry media_common.quotation_subject Unprotected intercourse Physiology Early pregnancy factor Mifepristone Biological effect Progesterone receptor biology.protein medicine Prostaglandin analogue business Menstrual cycle media_common medicine.drug |
| Zdroj: | Fertility Control — Update and Trends ISBN: 9783642866982 |
| Popis: | Mifepristone (Roussel Uclaf, Paris, France) is an antiprogestin which binds to the progesterone receptor, thereby preventing progesterone from expressing its biological effect. Mifepristone, in combination with a prostaglandin analogue, is used for termination of early pregnancy in several countries, including Sweden [3, 17]. The use of antiprogestins for contraceptive purposes is currently being evaluated and recent results indicate that this may very well be possible. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|